Key Takeaways Suzano will hold 51% of a $3.4B tissue joint venture with Kimberly-Clark, transaction to close in mid-2026. The JV spans 22 plants across 14 countries with 1M-ton annual output and $3.3B in 2024 net sales. Suzano will pay $1.734B in cash at closing, aligning with its strategy of scalable, efficient growth.Suzano S.A. (SUZ) and Kimberly-Clark Corporation (KMB) announced that they would create a $3.4-billion joint venture that will manufacture consumer and professional tissue products. Suzano ...

Key Takeaways Musk-Trump clash erases $150B from TSLA's value in its worst single-day drop on record. Trump vows to axe Tesla's federal support, putting EV credits and contracts on the chopping block. Tesla faces slumping global sales and growing U.S. regulatory scrutiny of its robotaxi project.Well, they didn’t exactly seem like besties forever, but neither did we expect things to get this ugly between Elon Musk, the richest man in the world and Tesla’s (TSLA) CEO, and US President Donald Trump. In fact, ...

Key Takeaways TGT's Q1 gross margin got a 120-bps lift from shrink gains, offsetting markdowns and fulfillment costs. Despite a 2.8% sales drop, operating income rose 13.6% due to the shrink-driven margin improvement. Target must focus on merchandising, cost efficiencies and pricing strategies to sustain or grow margins.Target Corporation’s (TGT) first-quarter fiscal 2025 gross margin rate of 28.2% was down 60 basis points year over year, but it could have been worse. The company reported about 120 basis ...

Core Insights - ABM Industries reported revenue of $2.11 billion for the quarter ended April 2025, reflecting a year-over-year increase of 4.6% and a surprise of +2.24% over the Zacks Consensus Estimate of $2.07 billion [1] - The company's EPS was $0.86, slightly down from $0.87 in the same quarter last year, resulting in an EPS surprise of -1.15% compared to the consensus estimate of $0.87 [1] Revenue Performance - Business & Industry segment generated $1.02 billion, exceeding the average estimate of $1 billion, with a year-over-year change of +2.6% [4] - Aviation segment reported revenues of $260.10 million, slightly above the average estimate of $260.07 million, marking a year-over-year increase of +9.2% [4] - Education segment achieved revenues of $227.80 million, below the average estimate of $229.60 million, with a year-over-year change of +1% [4] - Manufacturing & Distribution segment reported $398.10 million, surpassing the average estimate of $380.52 million, reflecting a year-over-year increase of +2.4% [4] - Technical Solutions segment generated $210.20 million, below the average estimate of $224.17 million, but showing a significant year-over-year increase of +19.3% [4] Operating Profit Analysis - Operating profit for the Aviation segment was $16.50 million, below the average estimate of $18.70 million [4] - Business & Industry segment's operating profit was $83 million, compared to the average estimate of $86.81 million [4] - Manufacturing & Distribution segment reported an operating profit of $39.90 million, below the average estimate of $47.43 million [4] - Education segment's operating profit was $13.80 million, compared to the average estimate of $14.86 million [4] - Technical Solutions segment reported an operating profit of $13.40 million, below the average estimate of $19.22 million [4] - Corporate segment reported an operating loss of -$82.90 million, which was better than the average estimate of -$101.64 million [4] Stock Performance - Shares of ABM Industries have returned +1% over the past month, while the Zacks S&P 500 composite increased by +5.3% [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

From a technical perspective, Verve Therapeutics (VERV) is looking like an interesting pick, as it just reached a key level of support. VERV recently overtook the 200-day moving average, and this suggests a long-term bullish trend.The 200-day simple moving average is widely-used by traders and analysts, and helps establish market trends for stocks, commodities, indexes, and other financial instruments over the long term. The indicator moves higher or lower together with longer-term price moves, serving as a ...

Roku (ROKU) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ROKU broke through the 200-day moving average, which suggests a long-term bullish trend.The 200-day simple moving average is a useful tool for traders and analysts, establishing market trends for stocks, commodities, indexes, and other financial instruments over the long term. The marker moves higher or lower along with longer-term price moves, and serves as a support or resistance ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about The Trade Desk (TTD) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.The Trade Desk currently has an avera ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about Ouster, Inc. (OUST) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Ouster currently has an average broker ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about MercadoLibre (MELI) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.MercadoLibre currently has an average ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...